Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

13.76 -0.66 (-4.58%)
Official Closing Price Updated: 6:30 PM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemours Company (The) Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Where Chemours Stands With Analysts
 
Via Benzinga
Investment Company Luminus Loaded Up on This Leading Industrials Stock. Is It a Buy?
Via The Motley Fool
Topics Regulatory Compliance
Luminus Dumps About 43,000 Quaker Chemical Shares Worth $5.6 Million
Via The Motley Fool
Topics Regulatory Compliance World Trade
Luminus Trims Its Hefty Chemours Position
Via The Motley Fool
Topics Regulatory Compliance
Beyond The Numbers: 4 Analysts Discuss Chemours Stock
 
Via Benzinga
Earnings Scheduled For August 5, 2025
 
Via Benzinga
A Look at Chemours's Upcoming Earnings Report
 
Via Benzinga
Assessing Chemours: Insights From 8 Financial Analysts
 
Via Benzinga
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending
Industrial stocks have started to pick up the pace in terms of price action, yet they are not even close to pricing in the growth potential 
Via MarketBeat
Topics Economy Stocks World Trade
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report
Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs. 
Via Benzinga
DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio
DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B. Deal aligns with DuPont's strategy to improve profitability and shareholders to benefit from Arclin's... 
Via Benzinga
Chemours (CC) Q2 EPS Jumps 53%
Via The Motley Fool
Earnings Scheduled For May 6, 2025
 
Via Benzinga
How Do Investors Really Feel About Chemours?
 
Via Benzinga
Deep Dive Into Chemours Stock: Analyst Perspectives (7 Ratings)
 
Via Benzinga
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Analyst Expectations For Chemours's Future
 
Via Benzinga
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields
 
Via Benzinga
6 Analysts Assess Chemours: What You Need To Know
 
Via Benzinga
Chemours Slides After Dividend Cut, Q1 Profit Miss: Retail’s Split As Management Bets On Data Center Cooling
The specialty chemicals firm reported a net loss of $4 million, or $0.03 per share, compared with a profit of $54 million, or $0.36 per share, a year earlier. 
Via Stocktwits
Topics Artificial Intelligence
Get insights into the top gainers and losers of Wednesday's after-hours session.
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields
 
Via Benzinga
What 6 Analyst Ratings Have To Say About Chemours
 
Via Benzinga
This Check Point Software Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday
 
Via Benzinga
The Analyst Verdict: Chemours In The Eyes Of 7 Experts
 
Via Benzinga
What Does the Market Think About Chemours?
 
Via Benzinga
Chemours, Energy Fuels Team Up to Advance Domestic Rare Earth Production
Chemours and Energy Fuels partner to boost US domestic supply chains for rare earth elements and minerals. Collaboration to support White Mesa Mill. 
Via Benzinga
Chemours Leads Product Trial to Cut Data Center Cooling Energy Use by 90%: Details
Chemours joins forces with NTT DATA and Hibiya Engineering, Ltd. to advance data center two-phase immersion cooling with Opteon 2P50. 
Via Benzinga
Chemours (CC) Q4 2024 Earnings Call Transcript
CC earnings call for the period ending December 31, 2024. 
Via The Motley Fool
Topics Earnings
Chemours Q4 Earnings: Mixed Results, Moderate Outlook, 'Pathway To Thrive' In Action & More
Chemours Company reports Q4 net sales of $1.359 billion, in line with consensus. Adjusted EBITDA improved 2% Y/Y. FY25 outlook positive. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.